Developer docs
API playgroundTry for free, no card

Search company profiles

MitoAction

Full company profile

uuid000grzy

Namestring
MitoAction
Legal namestring
MitoAction
Websiteurl
mitoaction.org
Company typeenum
Private
Founded yearint
2007
Descriptiontext

MitoAction is a U.S. 501(c)(3) nonprofit organization founded in 2007 and headquartered in Novi, Michigan, that delivers support, education, outreach, and advocacy services to patients and families affected by mitochondrial disease and fatty acid oxidation disorders (FAODs). Its core programmatic portfolio includes the Mito411 peer support hotline (1-888-MITO-411), recurring condition-specific support calls (Weekly, Men's, FAOD, POLG, MELAS, CPEO & Me), MitoSocials and MitoPlaydates, the Monthly Expert Series and Wondering Wednesdays webinars, the Energy in Action podcast, and community fundraising walks (Energy Walks in NY, MA, TX, FL, CA) plus the annual International Metabolic Conference for FAOD families. Complementary programs include the Dalia's Wish wish-granting initiative, the Matthew Harty Camper Fund and Scholarship (45+ scholarships awarded), Marcel's Way Family Fund, Positive Peach Packages, Mito Champions volunteer program, and a searchable Mitochondrial Disease Doctor Directory covering all 50 U.S. states with telehealth options.

The organization's technology centerpiece is the MyMito App, described as the first and only HIPAA-compliant digital health platform purpose-built for mitochondrial disease, enabling patients and caregivers to manage care, track symptoms, and coordinate with their care team. Distribution also runs through an e-commerce shop (79 SKUs including the Liney's Lovies sub-brand, priced $9.50–$75) and a content library of 125+ recorded expert presentations. MitoAction co-develops the Mitochondrial Care Network with the United Mitochondrial Disease Foundation and Mitochondrial Medicine Society, connecting 18 Mitochondrial Medicine Centers and 3 affiliate sites, and maintains collaborative relationships with at least six clinical-stage biotech and pharma companies (Ultragenyx, Tisento, Stealth Bio, Khondrion, Pretzel, BPGbio) plus the POLG Foundation and INFORM.

The revenue model is non-commercial: services are provided free of charge and the operating budget is funded through tax-deductible individual donations (Federal Tax ID 55-0899427), corporate sponsorships and grants, fundraising events (Energy Walks, Derby Day Benefit, Giving Tuesday), matching gifts, and merchandise sales. Go-to-market is community-led and event-driven — peer support calls, educational webinars, the podcast, social media (Facebook, Instagram, X), and signature in-person events — rather than paid acquisition. No headcount, revenue, or financial statements are publicly disclosed.

Short descriptiontext

MitoAction is a U.S. 501(c)(3) nonprofit (founded 2007) that provides support, education, and advocacy services — including the MyMito HIPAA-compliant app, Mito411 hotline, peer support calls, and Energy Walks — to patients and families affected by mitochondrial disease and fatty acid oxidation disorders.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mitochondrial disease support, patient advocacy services, rare disease education, nonprofit patient outreach, community health support
SIC code3 codes
  • Services-Social Services8300
  • Services-Health Services8000
  • Services-Membership Organizations8600
Product category
Rare Disease Patient Advocacy and Support Services
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Donations
TypeGrants Donations
Description

Tax-deductible donations from individual donors, families, and supporters. Donations can be made online through their platform or by mail. Federal tax ID: 55-0899427.

mitoaction.org
2Merchandise Sales
TypeHardware Sales
Description

The organization operates an online shop selling branded merchandise including apparel (mugs, t-shirts, hoodies, socks), accessories (hats, beanies), and awareness items. Products are priced between $9.50 and $75.00.

mitoaction.org
3Event Fundraising
TypeGrants Donations
Description

Revenue generated from events including Energy Walks, Derby Day Benefit, and other fundraising activities. Corporate sponsorships from companies like BPGbio support specific events.

mitoaction.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details1 tier
1Merchandise items including mugs, t-shirts, hoodies, socks, hats, and beanies
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Prices range from $9.50 (Liney's Lovies Black Glossy Mug) to $75.00 (MitoAction Quarter Zip Pullover). Most apparel items fall in the $20-$40 range.

mitoaction.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

MitoAction is a nonprofit organization that delivers direct support, education, outreach, and advocacy services to individuals and families affected by mitochondrial disease. Its portfolio includes a mobile application (MyMito App), a telephone support hotline (Mito411), educational webinars and podcasts, peer support calls, and community events, most of which are offered free of charge to patients and caregivers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

MitoAction is a nonprofit organization offering a comprehensive portfolio of programs, services, and digital tools for the mitochondrial disease community. The core offerings include the MyMito App (a HIPAA-compliant mobile platform for health management and care team coordination), the Mito411 support hotline, various peer support programs (Support Calls, MitoSocials, MitoPlaydates), educational resources (Monthly Expert Series, Energy in Action Podcast, New Patient Kits, Wondering Wednesdays), community fundraising events (Energy Walks, International Metabolic Conference), and access to a Mitochondrial Care Network of specialized doctors. The organization also operates a merchandise shop with products like Liney's Lovies. These offerings work together to provide support, education, outreach, and advocacy for children and adults living with mitochondrial disease and fatty acid oxidation disorders.

Product and service1 record
1MyMito App
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1United Mitochondrial Disease Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates with United Mitochondrial Disease Foundation as part of the Mitochondrial Care Network initiative to improve quality of mitochondrial patient care and implement best practices and standards of care.

mitoaction.org
2Mitochondrial Medicine Society
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborates with the Mitochondrial Medicine Society (MMS) on the Mitochondrial Care Network, which brings together mitochondrial physicians to establish standards of care and advance clinical practice.

mitoaction.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on POLG Support Call series, a support group for individuals and families affected by POLG-related mitochondrial disorders.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership on clinical trial information and patient resources for FAODs including MCADD. Ultragenyx sponsors study recruitment and provides updates on clinical development programs.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration on MELAS patient-focused drug development meeting and clinical trial information for mitochondrial disease treatments.

6Stealth Bio Therapeutics
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration related to FDA approval of FORZINITY (elamipretide) for Barth syndrome, the first approved mitochondria-targeted therapeutic.

mitoaction.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership related to clinical trials for sonlicromanol in MELAS and other mitochondrial DNA mutations.

8BPGbio
Strategic tierMinorTypeGTM or Marketing Partner
Description

Corporate sponsor of MitoAction Energy Walk at Boston's Franklin Park Zoo. Represents pharmaceutical/biotech company commitment to mitochondrial disease community.

mitoaction.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership related to Phase 1 clinical study for PX579, a therapeutic in bioenergetics restoration.

10INFORM (International Network for Fatty Acid Oxidation Research and Management)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Dr. Jerry Vockley and Dr. Melanie Gillingham to present the International Metabolic Conference, bringing together experts to present to patients, families, caregivers, and clinicians about FAOD disease management and clinical trials.

mitoaction.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

U.S. rare-disease patient advocacy umbrella offering toolkits, RARE summits, and grants; overlapping audience but broader scope than MitoAction's mito-specific niche.

2United Mitochondrial Disease Foundation
TypeDirect peer
Description

Largest U.S. patient advocacy organization focused on mitochondrial disease; directly comparable mission (support, research, education) and an explicit partner of MitoAction on the Mitochondrial Care Network.

3Children's Mitochondrial Disease Network
TypeDirect peer
Description

U.K.-based support network for families affected by mitochondrial disease, offering family liaison and educational resources comparable to MitoAction's Mito411 and New Patient Kit.

TypeBroad incumbent
Description

U.S. umbrella advocacy organization for all rare diseases; MitoAction is a NORD member and competes for the same donor/grant pool while operating a narrower disease focus.

TypeRegional player
Description

Canadian mitochondrial disease patient advocacy nonprofit offering support, education, and awareness programs; mirrors MitoAction's community-led model in a different geography.

TypeDirect peer
Description

U.S. nonprofit dedicated to a specific mitochondrial subtype (ATAD3A); smaller, narrowly focused advocacy peer operating a similar support/education/research model.

TypeBroad incumbent
Description

Nonprofit coalition advancing genetics policy and patient engagement; serves as a peer umbrella and policy advocate that overlaps with MitoAction's medical-professional and policy work.

TypeBroad incumbent
Description

European alliance of rare-disease patient organizations across 70+ countries; broader incumbent that MitoAction is a member of and that competes for international advocacy mindshare.

TypeRegional player
Description

Australian mitochondrial disease organization providing patient support, research funding, and awareness; another geographic mirror of MitoAction's integrated support-plus-education model.

TypeRegional player
Description

Leading U.K. mitochondrial disease charity funding research and supporting patients/families; structurally analogous to MitoAction but serving a different national market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MitoAction

Rare Disease Patient Advocacy and Support Servicesmitoaction.org

MitoAction is a U.S. 501(c)(3) nonprofit (founded 2007) that provides support, education, and advocacy services — including the MyMito HIPAA-compliant app, Mito411 hotline, peer support calls, and Energy Walks — to patients and families affected by mitochondrial disease and fatty acid oxidation disorders.

What MitoAction does

MitoAction is a U.S. 501(c)(3) nonprofit organization founded in 2007 and headquartered in Novi, Michigan, that delivers support, education, outreach, and advocacy services to patients and families affected by mitochondrial disease and fatty acid oxidation disorders (FAODs). Its core programmatic portfolio includes the Mito411 peer support hotline (1-888-MITO-411), recurring condition-specific support calls (Weekly, Men's, FAOD, POLG, MELAS, CPEO & Me), MitoSocials and MitoPlaydates, the Monthly Expert Series and Wondering Wednesdays webinars, the Energy in Action podcast, and community fundraising walks (Energy Walks in NY, MA, TX, FL, CA) plus the annual International Metabolic Conference for FAOD families. Complementary programs include the Dalia's Wish wish-granting initiative, the Matthew Harty Camper Fund and Scholarship (45+ scholarships awarded), Marcel's Way Family Fund, Positive Peach Packages, Mito Champions volunteer program, and a searchable Mitochondrial Disease Doctor Directory covering all 50 U.S. states with telehealth options.

The organization's technology centerpiece is the MyMito App, described as the first and only HIPAA-compliant digital health platform purpose-built for mitochondrial disease, enabling patients and caregivers to manage care, track symptoms, and coordinate with their care team. Distribution also runs through an e-commerce shop (79 SKUs including the Liney's Lovies sub-brand, priced $9.50–$75) and a content library of 125+ recorded expert presentations. MitoAction co-develops the Mitochondrial Care Network with the United Mitochondrial Disease Foundation and Mitochondrial Medicine Society, connecting 18 Mitochondrial Medicine Centers and 3 affiliate sites, and maintains collaborative relationships with at least six clinical-stage biotech and pharma companies (Ultragenyx, Tisento, Stealth Bio, Khondrion, Pretzel, BPGbio) plus the POLG Foundation and INFORM.

The revenue model is non-commercial: services are provided free of charge and the operating budget is funded through tax-deductible individual donations (Federal Tax ID 55-0899427), corporate sponsorships and grants, fundraising events (Energy Walks, Derby Day Benefit, Giving Tuesday), matching gifts, and merchandise sales. Go-to-market is community-led and event-driven — peer support calls, educational webinars, the podcast, social media (Facebook, Instagram, X), and signature in-person events — rather than paid acquisition. No headcount, revenue, or financial statements are publicly disclosed.

MitoAction firmographics

Firmographics
Name
MitoAction
Legal name
MitoAction
Website
https://mitoaction.org
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
MitoAction is a U.S. 501(c)(3) nonprofit (founded 2007) that provides support, education, and advocacy services — including the MyMito HIPAA-compliant app, Mito411 hotline, peer support calls, and Energy Walks — to patients and families affected by mitochondrial disease and fatty acid oxidation disorders.
Ownership category
akta.pro rank

Where MitoAction is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MitoAction business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Donations: Tax-deductible donations from individual donors, families, and supporters. Donations can be made online through their platform or by mail. Federal tax ID: 55-0899427.
  2. Merchandise Sales: The organization operates an online shop selling branded merchandise including apparel (mugs, t-shirts, hoodies, socks), accessories (hats, beanies), and awareness items. Products are priced between $9.50 and $75.00.
  3. Event Fundraising: Revenue generated from events including Energy Walks, Derby Day Benefit, and other fundraising activities. Corporate sponsorships from companies like BPGbio support specific events.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goMerchandise items including mugs, t-shirts, hoodies, socks, hats, and beanies

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

MitoAction product offering

Product offering

Core offering

MitoAction is a nonprofit organization that delivers direct support, education, outreach, and advocacy services to individuals and families affected by mitochondrial disease. Its portfolio includes a mobile application (MyMito App), a telephone support hotline (Mito411), educational webinars and podcasts, peer support calls, and community events, most of which are offered free of charge to patients and caregivers.

Product overview

MitoAction is a nonprofit organization offering a comprehensive portfolio of programs, services, and digital tools for the mitochondrial disease community. The core offerings include the MyMito App (a HIPAA-compliant mobile platform for health management and care team coordination), the Mito411 support hotline, various peer support programs (Support Calls, MitoSocials, MitoPlaydates), educational resources (Monthly Expert Series, Energy in Action Podcast, New Patient Kits, Wondering Wednesdays), community fundraising events (Energy Walks, International Metabolic Conference), and access to a Mitochondrial Care Network of specialized doctors. The organization also operates a merchandise shop with products like Liney's Lovies. These offerings work together to provide support, education, outreach, and advocacy for children and adults living with mitochondrial disease and fatty acid oxidation disorders.

Differentiator

Problem solved

Functional benefit

Products and services

  • MyMito App

Companies that use MitoAction

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles1 record

MitoAction technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

MitoAction partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • United Mitochondrial Disease FoundationcoreStrategic or Co-development PartnerCollaborates with United Mitochondrial Disease Foundation as part of the Mitochondrial Care Network initiative to improve quality of mitochondrial patient care and implement best practices and standards of care.
  • Mitochondrial Medicine SocietycoreStrategic or Co-development PartnerCollaborates with the Mitochondrial Medicine Society (MMS) on the Mitochondrial Care Network, which brings together mitochondrial physicians to establish standards of care and advance clinical practice.
  • The POLG FoundationcoreStrategic or Co-development PartnerCollaboration on POLG Support Call series, a support group for individuals and families affected by POLG-related mitochondrial disorders.
  • UltragenyxminorStrategic or Co-development PartnerPartnership on clinical trial information and patient resources for FAODs including MCADD. Ultragenyx sponsors study recruitment and provides updates on clinical development programs.
  • Tisento TherapeuticsminorStrategic or Co-development PartnerCollaboration on MELAS patient-focused drug development meeting and clinical trial information for mitochondrial disease treatments.
  • Stealth Bio TherapeuticsminorStrategic or Co-development PartnerCollaboration related to FDA approval of FORZINITY (elamipretide) for Barth syndrome, the first approved mitochondria-targeted therapeutic.
  • KhondrionminorStrategic or Co-development PartnerPartnership related to clinical trials for sonlicromanol in MELAS and other mitochondrial DNA mutations.
  • BPGbiominorGTM or Marketing PartnerCorporate sponsor of MitoAction Energy Walk at Boston's Franklin Park Zoo. Represents pharmaceutical/biotech company commitment to mitochondrial disease community.
  • Pretzel TherapeuticsminorStrategic or Co-development PartnerPartnership related to Phase 1 clinical study for PX579, a therapeutic in bioenergetics restoration.
  • INFORM (International Network for Fatty Acid Oxidation Research and Management)coreStrategic or Co-development PartnerPartnership with Dr. Jerry Vockley and Dr. Melanie Gillingham to present the International Metabolic Conference, bringing together experts to present to patients, families, caregivers, and clinicians about FAOD disease management and clinical trials.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

MitoAction competitors and assessment

Company assessment

Emerging players

  • Global Genes: U.S. rare-disease patient advocacy umbrella offering toolkits, RARE summits, and grants; overlapping audience but broader scope than MitoAction's mito-specific niche.

Direct peers

  • United Mitochondrial Disease Foundation: Largest U.S. patient advocacy organization focused on mitochondrial disease; directly comparable mission (support, research, education) and an explicit partner of MitoAction on the Mitochondrial Care Network.
  • Children's Mitochondrial Disease Network: U.K.-based support network for families affected by mitochondrial disease, offering family liaison and educational resources comparable to MitoAction's Mito411 and New Patient Kit.
  • The Champ Foundation: U.S. nonprofit dedicated to a specific mitochondrial subtype (ATAD3A); smaller, narrowly focused advocacy peer operating a similar support/education/research model.

Broad incumbents

  • National Organization for Rare Disorders (NORD): U.S. umbrella advocacy organization for all rare diseases; MitoAction is a NORD member and competes for the same donor/grant pool while operating a narrower disease focus.
  • Genetic Alliance: Nonprofit coalition advancing genetics policy and patient engagement; serves as a peer umbrella and policy advocate that overlaps with MitoAction's medical-professional and policy work.
  • EURORDIS – Rare Diseases Europe: European alliance of rare-disease patient organizations across 70+ countries; broader incumbent that MitoAction is a member of and that competes for international advocacy mindshare.

Regional players

  • MitoCanada: Canadian mitochondrial disease patient advocacy nonprofit offering support, education, and awareness programs; mirrors MitoAction's community-led model in a different geography.
  • Mito Foundation: Australian mitochondrial disease organization providing patient support, research funding, and awareness; another geographic mirror of MitoAction's integrated support-plus-education model.
  • The Lily Foundation: Leading U.K. mitochondrial disease charity funding research and supporting patients/families; structurally analogous to MitoAction but serving a different national market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

MitoAction social profiles

Digital presence

MitoAction financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MitoAction leadership team

Management profile

Number of profiles

MitoAction funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MitoAction M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MitoAction

What does MitoAction do?

MitoAction is a nonprofit organization that delivers direct support, education, outreach, and advocacy services to individuals and families affected by mitochondrial disease. Its portfolio includes a mobile application (MyMito App), a telephone support hotline (Mito411), educational webinars and podcasts, peer support calls, and community events, most of which are offered free of charge to patients and caregivers.

Is MitoAction a public or private company?

MitoAction is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was MitoAction founded?

MitoAction was founded in 2007. It employs 11 to 50 people.

Where is MitoAction based?

MitoAction is headquartered in Boston, United States, in the North America region.

How does MitoAction make money?

Three revenue lines are on record. Donations are the primary driver. The others are merchandise Sales and event Fundraising.

Who are MitoAction's main competitors?

Global Genes is listed as an emerging player. Direct peers are United Mitochondrial Disease Foundation, Children's Mitochondrial Disease Network and The Champ Foundation. Broad incumbents are National Organization for Rare Disorders (NORD), Genetic Alliance and EURORDIS – Rare Diseases Europe. Regional players are MitoCanada, Mito Foundation and The Lily Foundation.

Does MitoAction have an API?

No public API is recorded for MitoAction.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialBuilt By The Mito Community: Mitoaction And Lumiio Launch New Mymito App For Families Living With Mitochondrial DiseaseMitoAction and Lumiio launched a redesigned MyMito app for families living with mitochondrial disease, rebuilt on Lumiio's platform. The free app offers seven functions including symptom tracking, health insights, and a shareable care card, and is available on the App Store and Google Play.EIN PresswireBuilt by the Mito Community: MitoAction and Lumiio Launch New MyMito App for Families Living With Mitochondrial DiseaseMitoAction and Lumiio launched a redesigned MyMito app for families living with mitochondrial disease, rebuilt on Lumiio's platform. The free app offers seven functions including symptom tracking, care contacts, and a shareable Care Card, co-created with the community. It is available on App Store and Google Play, with ongoing feedback guiding future updates.EIN PresswireBuilt by the Mito Community: MitoAction and Lumiio Launch New MyMito App for Families Living With Mitochondrial DiseaseMitoAction and Lumiio launched a redesigned MyMito app for families living with mitochondrial disease, rebuilt on Lumiio's platform. The free app offers seven functions including symptom tracking, health insights, and a shareable Care Card, co-created with the community. It is available now on App Store and Google Play.EIN PresswireMitoAction and The POLG Foundation to Co-Host Virtual Patient-Focused Drug Development MeetingMitoAction and The POLG Foundation will co-host a virtual Externally-Led Patient-Focused Drug Development meeting on POLG-related disorders on November 17, 2026. The event invites patients, caregivers, clinicians, and industry partners to share experiences with the FDA, with a pre-meeting survey closing October 31, 2026.EIN PresswireMitoAction and The POLG Foundation to Co-Host Virtual Patient-Focused Drug Development MeetingMitoAction and The POLG Foundation will co-host a virtual Externally-Led Patient-Focused Drug Development meeting on POLG-related disorders on November 17, 2026. The event invites patients, caregivers, clinicians, and industry partners to share experiences with the FDA, with a pre-meeting survey closing October 31, 2026.GlobeNewswireBPGbio Sponsors MitoAction Energy Walk at Boston’s Franklin Park Zoo on September 27th, 2025BPGbio announced its sponsorship of the MitoAction Energy Walk at Boston's Franklin Park Zoo on September 27, 2025, to raise awareness of mitochondrial diseases. The company is planning a Phase 3 trial for its investigational therapy BPM31510 targeting Primary CoQ10 Deficiency.PrwebMinions to Take Over MitoAction Energy Walk & 5K to Raise AwarenessComeau's Mito Minions will participate in the 12th annual MitoAction Energy Walk & 5K on Sept. 18 in South Boston, MA. The event raises awareness and funds for mitochondrial disease, a progressive condition affecting about 1 in 4,000 people with no cure.